Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus

被引:9
|
作者
Makita, Kenji [1 ]
Kitazawa, Riko [1 ]
Semba, Shuho [2 ]
Fujiishi, Koto [1 ]
Nakagawa, Miku [1 ]
Haraguchi, Ryuma [1 ]
Kitazawa, Sohei [1 ]
机构
[1] Ehime Univ, Grad Sch Med, Div Mol Pathol, Toon City, Ehime 7910295, Japan
[2] Kobe Univ, Grad Sch Med, Div Pathol, Kobe, Hyogo 6500017, Japan
关键词
Barretti's esophagus; Caudal type homebox transcription factor 2; Intestinal metaplasia; Promoter hypermethylation; GENE-EXPRESSION; MARKER; ADENOCARCINOMAS; MORPHOLOGY; ORIGIN;
D O I
10.3748/wjg.v19.i4.536
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To examine how the expression of caudal type homebox transcription factor 2 (Cdx2) is regulated in the development of malignancy in Barrett's esophagus. METHODS: Cdx2, mucin (MUC) series (MUC2, MUC5AC and MUC6), p53 and E-cadherin expression in Barrett's esophagus and adenocarcinoma specimens were examined by immunostaining. Isolated clusters of cells from (1) MUC2 and Cdx2-positive intestinal metaplastic mucosa; (2) MUC5AC and MUC6-positive, and MUC2 and Cdx2-negative high-grade dysplasia (HD), or intramucosal adenocarcinoma (IMC); and (3) MUC5AC, MUC6 and Cdx2-positive poorly-differentiated invasive adenocarcinoma (PDA) were analyzed by methylation-specific polymerase chain reaction using sets of primers for detecting methylation status of the Cdx2 gene. RESULTS: Most of the non-neoplastic Barrett's esophageal mucosa showing intestinal-type metaplasia with or without low-grade dysplasia was positive for E-cadherin, MUC series and Cdx2, but negative for p53. A portion of the low-grade to HD was positive for E-cadherin, MUC5AC, MUC6 and p53, but negative for MUC2 and Cdx2. The definite IMC area was strongly positive for MUC5AC, MUC6 and p53, but negative for MUC2 and Cdx2. Methylation of the Cdx2 promoter was not observed in intestinal metaplasia, while hypermethylation of part of its promoter was observed in hot dipped and IMC. Hypermethylation of a large fraction of the Cdx2 promoter was observed in PDA. CONCLUSION: Cdx2 expression is restored irrespective of the methylation status of its promoter. Apparent positive immunohistochemical results can be a molecular mark for gene silencing memory. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码:536 / 541
页数:6
相关论文
共 50 条
  • [41] SHH and CDx2 Expression in the Barrett's Epithelium
    Yamanaka, Yoshiyuki
    Shiotani, Akiko
    Fujimura, Yoshinori
    Imamura, Hiroshi
    Fujita, Minoru
    Tarumi, Ken-ichi
    Kamada, Tomoari
    Hata, Jiro
    Haruma, Ken
    [J]. GASTROENTEROLOGY, 2009, 136 (05) : A600 - A600
  • [42] Clinical biology of the Barrett's metaplasia, dysplasia to carcinoma sequence
    DeMeester, TR
    [J]. SURGICAL ONCOLOGY-OXFORD, 2001, 10 (03): : 91 - 102
  • [43] Barrett's oesophagus: Application of cDNA microarray technology to study molecular abnormalities in the metaplasia-dysplasia-carcinoma sequence.
    Shen, EF
    Wieand, D
    Landon, TH
    Wong, NA
    Lessells, AM
    Patterson-Brown, S
    Hillan, K
    Smith, V
    Penman, ID
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A290 - A290
  • [44] Expression of Cdx2 in Early GRCL of Barrett’s Esophagus Induced in Rats by Duodenal Reflux
    Takeshi Tatsuta
    Ken-ichi Mukaisho
    Hiroyuki Sugihara
    Koichi Miwa
    Tohru Tani
    Takanori Hattori
    [J]. Digestive Diseases and Sciences, 2005, 50 : 425 - 431
  • [45] Expression of Cdx2 in early GRCL of Barrett's esophagus induced in rats by duodenal reflux
    Tatsuta, T
    Mukaisho, K
    Sugihara, H
    Miwa, K
    Tani, T
    Hattori, T
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (03) : 425 - 431
  • [46] HER2 Expression in Dysplasia-Carcinoma Sequence of Barrett Esophagus and Its Role in the Different Pathways of Carcinogenesis in Barrett Esophagus
    Khor, Tze
    Ooi, Esther
    Srivastava, Amitabh
    Park, Do-Youn
    Lauwers, Gregory
    Kumarasinghe, Marian
    [J]. LABORATORY INVESTIGATION, 2015, 95 : 168A - 168A
  • [47] HER2 Expression in Dysplasia-Carcinoma Sequence of Barrett Esophagus, and Its Role in the Different Pathways of Carcinogenesis in Barrett Esophagus
    Khor, Tze
    Ooi, Esther
    Srivastava, Amitabh
    Park, Do-Youn
    Lauwers, Gregory
    Kumarasinghe, Marian
    [J]. MODERN PATHOLOGY, 2015, 28 : 168A - 168A
  • [48] HER2 EXPRESSION IN THE BARRETT'S METAPLASIA-DYSPLASIA-CARCINOMA SEQUENCE AND POTENTIAL TARGETING IN VITRO WITH THE SINGLE CHAIN ANTIBODY FRAGMENT C6.5
    Butt, M. A.
    Haidry, R. J.
    Oukrif, D.
    Pye, H.
    Stamati, I.
    Yahioglu, G.
    Rodriguez-Justo, M.
    Banks, M. R.
    Deonarain, M. P.
    Novelli, M. R.
    Lovat, L. B.
    [J]. GUT, 2012, 61 : A302 - A303
  • [49] CDX2 protein expression in esophageal biopsies without histological evidence of intestinal metaplasia may predict the presence of undetected Barrett's esophagus
    Saller, James
    Al Diffalha, Sameer
    Neill, Kevin
    Oliveri, Cecilia
    Levine, Hank
    Boulware, David
    Coppola, Domenico
    [J]. MODERN PATHOLOGY, 2018, 31 : 300 - 300
  • [50] CDX2 protein expression in esophageal biopsies without histological evidence of intestinal metaplasia may predict the presence of undetected Barrett's esophagus
    Saller, James
    Al Diffalha, Sameer
    Neill, Kevin
    Oliveri, Cecilia
    Levine, Hank
    Boulware, David
    Coppola, Domenico
    [J]. LABORATORY INVESTIGATION, 2018, 98 : 300 - 300